Aspire Capital Fund LLC 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-02 06:21 am Purchase | 2020-07-01 | 13G | Akari Therapeutics, Plc AKTX | Aspire Capital Fund LLC | 33,679,045 19.890% | 33,679,045 (New Position) | Filing |